Hans P S, England R, Prowse S, Young E, Sheehan P Z
ENT and Hearing Clinic for Children with Down Syndrome, Department of Paediatric Otorhinolaryngology, Royal Manchester Children's Hospital, Oxford Road, Manchester M13 9WL, United Kingdom.
Int J Pediatr Otorhinolaryngol. 2010 Mar;74(3):260-4. doi: 10.1016/j.ijporl.2009.11.018. Epub 2009 Dec 24.
Down Syndrome (DS) is associated with a high incidence of hearing loss. The majority of hearing loss is conductive, but between 4 and 20% is sensorineural, which in the main is mild or moderate and is managed with conventional behind-the-ear hearing aids. Cochlear implantation is an elective invasive procedure, performed to provide some form of hearing rehabilitation in individuals with severe to profound sensorineural hearing loss, and initially candidacy criteria were strict--excluding patients with additional disabilities. With good results and expanding experience, more candidates with additional disabilities are now being implanted. A survey of UK and Ireland Cochlear Implant Programmes sought to identify the number of individuals with DS who have been implanted with a cochlear implant (CI) and to provide relevant information on outcomes of implantation in these individuals.
E-mail survey of all programmes within the British Cochlear Implant Group (BCIG). Postal questionnaire to programmes identified to have implanted a child with Down Syndrome, with data collection on pre-operative assessment, surgical and post-operative outcomes. Case series review.
Three of 23 BCIG programmes have implanted a child with Down Syndrome. Four children have received implants. No intraoperative or post-operative surgical complications were encountered. All children had middle ear disease, but no problems with implantation were associated with their middle ear condition. All children remain implant users, 12 months to 4 years post-implantation.
Cochlear implantation is an option for a child with Down Syndrome and associated severe to profound sensorineural hearing loss. Clinicians caring for these children and their families should consider referral for assessment by a Cochlear Implant Programme.
唐氏综合征(DS)与听力损失的高发病率相关。大多数听力损失为传导性,但4%至20%为感音神经性,主要为轻度或中度,可使用传统的耳背式助听器进行治疗。人工耳蜗植入是一种选择性侵入性手术,用于为重度至极重度感音神经性听力损失的个体提供某种形式的听力康复,最初的候选标准很严格——排除有其他残疾的患者。随着良好的效果和经验的积累,现在有更多有其他残疾的候选者接受了植入。一项对英国和爱尔兰人工耳蜗植入项目的调查旨在确定植入人工耳蜗(CI)的唐氏综合征个体数量,并提供这些个体植入结果的相关信息。
对英国人工耳蜗植入小组(BCIG)内的所有项目进行电子邮件调查。向已确定为唐氏综合征儿童植入人工耳蜗的项目邮寄问卷,收集术前评估、手术及术后结果的数据。进行病例系列回顾。
23个BCIG项目中有3个为唐氏综合征儿童植入了人工耳蜗。4名儿童接受了植入。未遇到术中或术后手术并发症。所有儿童均患有中耳疾病,但植入未因中耳状况出现问题。所有儿童在植入后12个月至4年仍为人工耳蜗使用者。
人工耳蜗植入是患有唐氏综合征及相关重度至极重度感音神经性听力损失儿童的一种选择。照顾这些儿童及其家庭的临床医生应考虑将其转诊至人工耳蜗植入项目进行评估。